Pre-made benchmark antibody with INN name
Virus-like particles (VLP) Platforms for immunogens, vaccines and drug carriers
Antibody-drug Conjugate (ADC): Pre-made ADC benchmark, MOA, Production and QC
Neutralizing antibodies of virus (SARS2, HIV, HBV, Rabies, RSV, Ebola, Influenza)
Immunoglobulin Fc receptors for Fc&Fc Receptor binding assay
ILIBRA-HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)
Single domain antibody (Nanobody)
SOCAIL MEDIA
GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about 
INN information from WHO
Product list
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
|---|---|---|---|---|---|---|
Pre-Made Eflimrufusp Alfa Biosimilar, Fusion Protein targeting FGF2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BFGF/FGF-2/FGFB/HBGF-2 |
eflimrufusp alfa |
NA |
FGF2 |
Fusion Protein |
||
Pre-Made Efmarodocokin Alfa Biosimilar, Fusion Protein targeting IL22RA1/IL22R1 fused with human IGHG4 Fc (Fragment constant): Recombinant therapeutic protein targeting CRF2-9 |
efmarodocokin alfa |
NA |
IL22RA1 |
Fusion Protein |
||
Pre-Made Efmitermant Alfa Biosimilar, Fusion Protein targeting MSTN/GDF-8 fused with human IGHG2 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting GDF8/MSLHP |
efmitermant alfa |
NA |
MSTN |
Fusion Protein |
||
Pre-Made Efmoroctocog Alfa Biosimilar, Fusion Protein targeting F8 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AHF/F8B/F8C/HEMA/FVIII/DXS1253E |
efmoroctocog alfa |
NA |
F8 |
Fusion Protein |
||
Pre-Made Efruxifermin Biosimilar, Fusion Protein targeting FGFR1 fused with human IGHG1 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting BFGFR/CD331/CEK/ECCL/FG |
efruxifermin |
NA |
FGFR1 |
Fusion Protein |
||
Pre-Made Eftansomatropin Alfa Biosimilar, Fusion Protein targeting GHR fused with human IGHG4 Fc (Fragment constant): Recombinant therapeutic protein targeting GHBP/GHIP |
eftansomatropin alfa |
NA |
GHR |
Fusion Protein |
||
Pre-Made Eftilagimod Alfa biosimilar, Fusion Protein: Recombinant therapeutic protein targeting MH2 fused with human IGHG1 Fc (Fragment constant) |
eftilagimod alfa |
NA |
MH2 |
Fusion Protein |
||
Pre-Made Eftozanermin Alfa Biosimilar, Fusion Protein targeting TNFRSF10B/TRAIL-R2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD262/DR5/KILLER/KILLER/DR5 |
eftozanermin alfa |
NA |
TNFRSF10B |
Fusion Protein |
||
Pre-Made Eftrenonacog Alfa Biosimilar, Fusion Protein targeting F9 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting FIX/P19/PTC/HEMB/THPH8 |
eftrenonacog alfa |
NA |
F9 |
Fusion Protein |
||
Pre-Made Elsilimomab Biosimilar, Whole Mab, Anti-Il6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody |
elsilimomab |
NA |
IL6 |
Whole mAb |
||
Pre-Made Enapotamab Vedotin Biosimilar, Whole Mab Adc, Anti-Axl Antibody: Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody Drug Conjugate |
enapotamab vedotin |
NA |
AXL |
Whole mAb ADC |
||
Pre-Made Enfortumab Vedotin Biosimilar, Whole Mab Adc, Anti-PVRL4/NECTIN4 Antibody: Anti-EDSS1/LNIR/PRR4/nectin-4 therapeutic antibody Drug Conjugate |
enfortumab vedotin |
NA |
PVRL4 |
Whole mAb ADC |
||
Pre-Made Enlimomab Biosimilar, Whole Mab, Anti-ICAM1 Antibody: Anti-BB2/CD54/P3.58 therapeutic antibody |
enlimomab |
NA |
ICAM1 |
Whole mAb |
||
Pre-Made Ensomafusp Alfa Alfaiosimilar, Bispecific, Anti-Cd19; Tnfrsf9 Antibody: Anti-B4/CVID3;ILA/4-1BB/CDw137 therapeutic antibody |
ensomafusp alfa |
NA |
CD19,TNFRSF9 |
Bispecific |
||
Pre-Made Ensovibep biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting Severe?acute?respiratory syndrome?coronavirus?2 RBD |
ensovibep |
NA |
Severe?acute?respiratory syndrome?coronavirus?2 RBD |
Recombinant Protein |
||
Pre-Made Epitumomab Biosimilar, Whole Mab, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
epitumomab |
NA |
MS4A1 |
Whole mAb |
||
Pre-Made Epitumomab Cituxetan Biosimilar, Radiolabelled Antibody, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeu |
epitumomab cituxetan |
NA |
MUC1 |
Radiolabelled antibody |
||
Pre-Made Epoetin Alfa biosimilar, Recombinant Protein: Recombinant EPO(erythropoietin) therapeutic protein targeting EPOR Pre-made [INN Name] biosimilar, [Format] targeting [Target1/Target2]), recom |
epoetin alfa |
NA |
EPOR |
Recombinant Protein |
||
Pre-Made Eptacog Alfa (Actived Biosimilar, Recombinant Protein targeting F7: Recombinant therapeutic protein targeting SPCA |
eptacog alfa (actived) |
NA |
F7 |
Recombinant Protein |
||
Pre-Made Eramkafusp Alfa Biosimilar, Fusion Protein targeting MS4A1/CD20 fused with human IFNA2 (interferon alpha 2) via a peptidyl linker: Recombinant therapeutic protein targeting B1/Bp35/CVID5/FMC |
eramkafusp alfa |
NA |
MS4A1 |
Fusion Protein |
||
Pre-Made Erlizumab Biosimilar, Whole Mab, Anti-Itgb2 Antibody: Anti-CD18/LAD/LCAMB/LFA-1/MAC-1/MF17/MFI7 therapeutic antibody |
erlizumab |
NA |
ITGB2 |
Whole mAb |
||
Pre-Made Ertumaxomab Biosimilar, Bispecific, Anti-Cd3E;Erbb2 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody |
ertumaxomab |
NA |
CD3E,ERBB2 |
Bispecific |
||
Pre-Made Etanercept Biosimilar, Fusion Protein targeting TNF fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F |
etanercept |
NA |
TNF |
Fusion Protein |
||
Pre-Made Exbivirumab Biosimilar, Whole Mab: Anti-Hbv (Hepatitis B Virus) Surface Antigen (Hbsag) [Hepatitis B Virus] therapeutic antibody |
exbivirumab |
NA |
HBV (hepatitis B virus) surface antigen (HBsAg) [Hepatitis B virus] |
Whole mAb |
||
Pre-Made Faralimomab Biosimilar, Whole Mab, Anti-Ifna1 Antibody: Anti-IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D therapeutic antibody |
faralimomab |
NA |
IFNA1 |
Whole mAb |
||
Pre-Made Farletuzumab Ecteribulin Biosimilar, Whole Mab Adc, Anti-Folr1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD therapeutic antibody Drug Conjugate |
farletuzumab ecteribulin |
NA |
FOLR1 |
Whole mAb ADC |
||
Pre-Made Felvizumab Biosimilar, Whole Mab: Anti-Rsv (Respiratory Syncytial Virus) Glycoprotein F [Respiratory Syncytial Virus] therapeutic antibody |
felvizumab |
NA |
RSV (respiratory syncytial virus) glycoprotein F [Respiratory syncytial virus] |
Whole mAb |
||
Pre-Made Filgrastim Biosimilar, Recombinant Protein targeting CSF3R: Recombinant therapeutic protein targeting CD114/GCSFR/SCN7 |
filgrastim |
NA |
CSF3R |
Recombinant Protein |
||
Pre-Made Gavilimomab Biosimilar, Whole Mab, Anti-Bsg Antibody: Anti-5F7/CD147/EMMPRIN/EMPRIN/HAb18G/OK/TCSF therapeutic antibody |
gavilimomab |
NA |
BSG |
Whole mAb |
||
Pre-Made Gemtuzumab Ozogamicin Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody: Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody Drug Conjugate |
gemtuzumab ozogamicin |
NA |
CD33 |
Whole mAb ADC |
||
Pre-Made Glembatumumab Vedotin Biosimilar, Whole Mab Adc, Anti-Gpnmb Antibody: Anti-HGFIN/NMB/PLCA3 therapeutic antibody Drug Conjugate |
glembatumumab vedotin |
NA |
GPNMB |
Whole mAb ADC |
||
Pre-Made Glucagon Biosimilar, Recombinant Protein targeting GCGR: Recombinant therapeutic protein targeting GGR/GL-R/MVAH |
glucagon |
NA |
GCGR |
Recombinant Protein |
||
Pre-Made Grisnilimab Setaritox Biosimilar, Whole Mab Adc, Anti-Cd7 Antibody: Anti-GP40/LEU-9/TP41/Tp40 therapeutic antibody Drug Conjugate |
grisnilimab setaritox |
NA |
CD7 |
Whole mAb ADC |
||
Pre-Made Ibritumomab Tiuxetan Biosimilar, Radiolabelled Antibody, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
ibritumomab tiuxetan |
NA |
MS4A1 |
Radiolabelled antibody |
||
Pre-Made Igovomab Biosimilar, Radiolabelled Antibody, Anti-Muc16 Antibody: Anti-CA125 therapeutic antibody |
igovomab |
NA |
MUC16 |
Radiolabelled antibody |
||
Pre-Made Iladatuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Cd79B Antibody: Anti-AGM6/B29/IGB therapeutic antibody Drug Conjugate |
iladatuzumab vedotin |
NA |
CD79B |
Whole mAb ADC |
||
Pre-Made Imciromab Biosimilar, Radiolabelled Antibody: Anti-Myosin therapeutic antibody |
imciromab |
NA |
myosin |
Radiolabelled antibody |
||
Pre-Made Inbakicept biosimilar, Fusion Protein: Recombinant therapeutic protein targeting IL15 fused with human IGHG1 Fc (Fragment constant) |
inbakicept |
NA |
IL15 |
Fusion Protein |
||
Pre-Made Indatuximab Ravtansine Biosimilar, Whole Mab Adc, Anti-Sdc1 Antibody: Anti-CD138/SDC/SYND1/syndecan therapeutic antibody Drug Conjugate |
indatuximab ravtansine |
NA |
SDC1 |
Whole mAb ADC |
||
Pre-Made Indusatumab Vedotin Biosimilar, Whole Mab Adc, Anti-Gucy2C Antibody: Anti-DIAR6/GC-C/GUC2C/MECILIL/STAR therapeutic antibody Drug Conjugate |
indusatumab vedotin |
NA |
GUCY2C |
Whole mAb ADC |
||
Pre-Made Inolimomab Biosimilar, Whole Mab, Anti-Il2Ra Antibody: Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55 therapeutic antibody |
inolimomab |
NA |
IL2RA |
Whole mAb |
||
Pre-Made Inotuzumab Ozogamicin Biosimilar, Whole Mab Adc, Anti-Cd22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody Drug Conjugate |
inotuzumab ozogamicin |
NA |
CD22 |
Whole mAb ADC |
||
Pre-Made Insulin Biosimilar, Recombinant Protein targeting INSR: Recombinant therapeutic protein targeting CD220/HHF5 |
insulin |
NA |
INSR |
Recombinant Protein |
||
Pre-Made Insulin Efsitora Alfa Biosimilar, Fusion Protein targeting INSR fused with human IGHG2 Fc (Fragment constant): Recombinant therapeutic protein targeting CD220/HHF5 |
insulin efsitora alfa |
NA |
INSR |
Fusion Protein |
||
Pre-Made Interferon Alfa Biosimilar, Recombinant Protein targeting IFNAR1: Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC |
interferon alfa |
NA |
IFNAR1 |
Recombinant Protein |
||
Pre-Made Interferon Alfacon-1 Biosimilar, Recombinant Protein targeting IFNAR1: Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC |
interferon alfacon-1 |
NA |
IFNAR1 |
Recombinant Protein |
||
Pre-Made Interferon Beta Biosimilar, Recombinant Protein targeting IFNAR1: Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC |
interferon beta |
NA |
IFNAR1 |
Recombinant Protein |
||
Pre-Made Interferon Gamma Biosimilar, Recombinant Protein targeting IFNGR1: Recombinant therapeutic protein targeting CD119/IFNGR/IMD27A/IMD27B |
interferon gamma |
NA |
IFNGR1 |
Recombinant Protein |
||
Pre-Made Iodine (131I) Apamistamab Biosimilar, Radiolabelled Antibody, Anti-Ptprc Antibody: Anti-B220/CD45/CD45R/GP180/L-CA/LCA/LY5/T200 therapeutic antibody |
iodine (131I) apamistamab |
NA |
PTPRC |
Radiolabelled antibody |
||
Pre-Made Iodine (131I) Derlotuximab Biotin Biosimilar, Radiolabelled Antibody: Anti-Dna/Histone (H1) Complex therapeutic antibody |
iodine (131I) derlotuximab biotin |
NA |
DNA/histone (H1) complex |
Radiolabelled antibody |
